BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23791298)

  • 1. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
    Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
    Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
    J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin is increased in cardiac cachexia irrespective of body mass index.
    Araújo JP; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Eur J Heart Fail; 2009 Jun; 11(6):567-72. PubMed ID: 19359328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wasting as independent risk factor for mortality in chronic heart failure.
    Anker SD; Ponikowski P; Varney S; Chua TP; Clark AL; Webb-Peploe KM; Harrington D; Kox WJ; Poole-Wilson PA; Coats AJ
    Lancet; 1997 Apr; 349(9058):1050-3. PubMed ID: 9107242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
    Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
    Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
    McEntegart MB; Awede B; Petrie MC; Sattar N; Dunn FG; MacFarlane NG; McMurray JJ
    Eur Heart J; 2007 Apr; 28(7):829-35. PubMed ID: 17403719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.
    Ponikowski P; Piepoli M; Chua TP; Banasiak W; Francis D; Anker SD; Coats AJ
    Eur Heart J; 1999 Nov; 20(22):1667-75. PubMed ID: 10543930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal imbalance in relation to exercise intolerance and ventilatory inefficiency in chronic heart failure.
    Agapitou V; Dimopoulos S; Kapelios C; Karatzanos E; Manetos C; Georgantas A; Ntalianis A; Terrovitis J; Karga H; Nanas S
    J Heart Lung Transplant; 2013 Apr; 32(4):431-6. PubMed ID: 23402947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased catabolic activity in adipose tissue of patients with chronic heart failure.
    Szabó T; Postrach E; Mähler A; Kung T; Turhan G; von Haehling S; Anker SD; Boschmann M; Doehner W
    Eur J Heart Fail; 2013 Oct; 15(10):1131-7. PubMed ID: 23696611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia?
    Celik T; Yaman H
    Int J Cardiol; 2010 Oct; 144(2):319-20. PubMed ID: 19304331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
    Doehner W; Bunck AC; Rauchhaus M; von Haehling S; Brunkhorst FM; Cicoira M; Tschope C; Ponikowski P; Claus RA; Anker SD
    Eur Heart J; 2007 Apr; 28(7):821-8. PubMed ID: 17353227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin, anemia and left ventricular dimensions in patients with cardiac cachexia.
    Bozcali E; Polat V; Akbulut H; Ferzeyn Yavuzkir M; Karaca I
    Cardiology; 2013; 126(4):207-13. PubMed ID: 24051989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
    Fülster S; Tacke M; Sandek A; Ebner N; Tschöpe C; Doehner W; Anker SD; von Haehling S
    Eur Heart J; 2013 Feb; 34(7):512-9. PubMed ID: 23178647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-blockers modify the prognostic value of adiponectin in chronic heart failure.
    Van Berendoncks AM; Beckers P; Hoymans VY; Possemiers N; Coenen S; Elseviers MM; Vrints CJ; Conraads VM
    Int J Cardiol; 2011 Aug; 150(3):296-300. PubMed ID: 20488568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
    Davos CH; Doehner W; Rauchhaus M; Cicoira M; Francis DP; Coats AJ; Clark AL; Anker SD
    J Card Fail; 2003 Feb; 9(1):29-35. PubMed ID: 12612870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.